ENTO

Entero Therapeutics
ENTO

Overview Fund Trends Analyst Outlook Journalist POV

5 hedge funds and large institutions have $183K invested in Entero Therapeutics in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more ownership

Funds ownership: →

more capital invested

Capital invested by funds: $ → $
Holders
5
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$122K
2
+$6.67K
3
+$3.8K
4
UBS Group
UBS Group
Switzerland
+$552
5
Bank of America
Bank of America
North Carolina
+$27

Top Sellers

1
-$57
2
-$4
3
-$4
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$155K
2
$20.3K
3
$6.74K
4
$552
5
$27
6
$1
7
$1
8
$1